Insulin Syringes Market

An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needle, a barrel, and a plunger, and is available in various sizes. The size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.

Insulin Syringes Market contains market size and forecasts of Insulin Syringes in global, including the following market information:

• Global Insulin Syringes Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Insulin Syringes Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Insulin Syringes companies in 2021 (%)

The global Insulin Syringes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

3/10 CC Syringe Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Insulin Syringes include Novo Nordisk, Sanofi, Eli Lilly and Company, Biocon Ltd, Ypsomed AG, Wockhardt Ltd, Medtronic Plc, Abbott Laboratories and Animas Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Insulin Syringes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Insulin Syringes Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Syringes Market Segment Percentages, by Type, 2021 (%)

• 3/10 CC Syringe
• 1/2 CC Syringe
• 1 CC Syringe
• Others

Global Insulin Syringes Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Syringes Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Homecare
• Others

Global Insulin Syringes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Insulin Syringes Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Insulin Syringes revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Insulin Syringes revenues share in global market, 2021 (%)
• Key companies Insulin Syringes sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Insulin Syringes sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Sanofi
• Eli Lilly and Company
• Biocon Ltd
• Ypsomed AG
• Wockhardt Ltd
• Medtronic Plc
• Abbott Laboratories
• Animas Corporation
• F. Hoffmann-La Roche
• BD